FI116223B - TCF-mutantti - Google Patents

TCF-mutantti Download PDF

Info

Publication number
FI116223B
FI116223B FI963313A FI963313A FI116223B FI 116223 B FI116223 B FI 116223B FI 963313 A FI963313 A FI 963313A FI 963313 A FI963313 A FI 963313A FI 116223 B FI116223 B FI 116223B
Authority
FI
Finland
Prior art keywords
tcf
gly
leu
lys
pro
Prior art date
Application number
FI963313A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI963313A0 (fi
FI963313A (fi
Inventor
Kyoji Yamaguchi
Akihiko Murakami
Masaaki Goto
Masatsugu Ueda
Kanji Higashio
Fumie Kobayashi
Masahiko Kinosaki
Yasushi Yamashita
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of FI963313A0 publication Critical patent/FI963313A0/fi
Publication of FI963313A publication Critical patent/FI963313A/fi
Application granted granted Critical
Publication of FI116223B publication Critical patent/FI116223B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI963313A 1994-12-27 1996-08-26 TCF-mutantti FI116223B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP33788594 1994-12-27
JP33788594 1994-12-27
JP9502708 1995-12-27
PCT/JP1995/002708 WO1996020214A1 (fr) 1994-12-27 1995-12-27 Mutant de tcf

Publications (3)

Publication Number Publication Date
FI963313A0 FI963313A0 (fi) 1996-08-26
FI963313A FI963313A (fi) 1996-08-26
FI116223B true FI116223B (fi) 2005-10-14

Family

ID=18312917

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963313A FI116223B (fi) 1994-12-27 1996-08-26 TCF-mutantti

Country Status (16)

Country Link
US (2) US6399744B1 (xx)
EP (2) EP0757994B1 (xx)
JP (1) JP3699482B2 (xx)
KR (1) KR100294328B1 (xx)
AT (1) ATE248913T1 (xx)
AU (1) AU698221B2 (xx)
CA (1) CA2183856C (xx)
DE (1) DE69531673T2 (xx)
DK (1) DK0757994T3 (xx)
ES (1) ES2206523T3 (xx)
FI (1) FI116223B (xx)
HU (1) HU220167B (xx)
NO (1) NO319022B1 (xx)
NZ (1) NZ298142A (xx)
WO (1) WO1996020214A1 (xx)
ZA (1) ZA9510982B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3699482B2 (ja) * 1994-12-27 2005-09-28 第一製薬株式会社 Ｔｃｆ変異体
JP4006058B2 (ja) 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
CA2253629A1 (en) 1997-03-14 1998-09-24 Snow Brand Milk Products Co., Ltd. Agent for preventing and/or treating cachexia
KR100552434B1 (ko) * 1997-03-28 2006-05-16 다이이치세이야꾸 가부시끼가이샤 신질환 예방 및/또는 치료제_
JP3961064B2 (ja) * 1997-03-28 2007-08-15 第一製薬株式会社 腎疾患予防及び／又は治療剤
GB9709453D0 (en) * 1997-05-10 1997-07-02 Imp Cancer Res Tech Polypedtides and their use in therapy
DE19909251A1 (de) 1998-02-21 1999-08-26 Max Delbrueck Centrum Mittel zur Therapie von menschlichen Erkrankungen, ausgehend von beta-Catenin, seine Herstellung und seine Verwendung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ232813A (en) * 1989-03-10 1992-08-26 Snow Brand Milk Products Co Ltd Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
EP0539590B1 (en) * 1990-07-13 1999-03-31 Snow Brand Milk Products Co., Ltd. Plasmid containing dna which codes for the amino acid sequence of tcf-ii, transformed cell, and production of physiologically active substance by using the same
ES2181689T3 (es) * 1992-05-18 2003-03-01 Genentech Inc Variantes del factor de crecimiento de hepatocitos.
KR100260964B1 (ko) * 1992-07-16 2000-07-01 쇼노 카츄야 Tcf-ii를 유효성분으로 하는 혈액응고 정상화제
HUT68170A (en) * 1992-12-28 1995-03-21 Snow Brand Milk Products Co Ltd Modified tumor cytotoxic factor /tcf/
JP3699482B2 (ja) * 1994-12-27 2005-09-28 第一製薬株式会社 Ｔｃｆ変異体
JP3961064B2 (ja) * 1997-03-28 2007-08-15 第一製薬株式会社 腎疾患予防及び／又は治療剤
JPH1129493A (ja) * 1997-07-14 1999-02-02 Snow Brand Milk Prod Co Ltd 放射線障害予防及び／又は治療剤

Also Published As

Publication number Publication date
NO963552L (no) 1996-10-28
EP1275718A3 (en) 2003-03-19
CA2183856A1 (en) 1996-06-28
WO1996020214A1 (fr) 1996-07-04
EP0757994A4 (en) 1998-10-21
AU698221B2 (en) 1998-10-29
ATE248913T1 (de) 2003-09-15
CA2183856C (en) 2006-11-07
DE69531673T2 (de) 2004-07-08
EP0757994A1 (en) 1997-02-12
HU9602174D0 (en) 1996-10-28
HUT75236A (en) 1997-04-28
EP0757994B1 (en) 2003-09-03
JP3699482B2 (ja) 2005-09-28
US20020165358A1 (en) 2002-11-07
DK0757994T3 (da) 2004-01-19
KR100294328B1 (ko) 2001-09-17
NO319022B1 (no) 2005-06-06
FI963313A0 (fi) 1996-08-26
KR970701206A (ko) 1997-03-17
DE69531673D1 (de) 2003-10-09
HU220167B (hu) 2001-11-28
ZA9510982B (en) 1996-08-22
EP1275718A2 (en) 2003-01-15
NZ298142A (en) 1997-08-22
FI963313A (fi) 1996-08-26
US6399744B1 (en) 2002-06-04
NO963552D0 (no) 1996-08-26
ES2206523T3 (es) 2004-05-16
AU4355196A (en) 1996-07-19

Similar Documents

Publication Publication Date Title
AU621358B2 (en) Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression
CA2194660C (en) Growth differentiation factor-11
CA2288218C (en) Novel differentiation-inhibitor
JP3205578B2 (ja) キメラ繊維芽細胞成長因子
EP0503297B1 (en) GLIA activating factor and its production
KR100353579B1 (ko) 섬유아세포성장인자의표면고리구조유사체
EP0679163A1 (en) Growth differentiation factor-3
CZ288890B6 (cs) MGDF polypeptid pro stimulaci růstu a diferenciaci megakaryocytů
US5929213A (en) Antibodies to growth differentiation factor-12
CA2329054A1 (en) A novel polypeptide hormone phosphatonin
NZ240623A (en) Fragments of basic fibroblast growth factor (bfgf)
EP0444149A1 (en) High molecular weight human angiogenic factors
WO1996018730A1 (en) Prostatic growth factor
FI116223B (fi) TCF-mutantti
CA2005600A1 (en) Endothelial cell growth factor
US20020099196A1 (en) Hematopoietic stem cell growth factor (scgf)
EP0241136A2 (en) Human class 1 heparin-binding growth factor
CA2509508C (en) Tcf mutant
US6103880A (en) HARP family growth factors
JP3292873B2 (ja) 組換肝実質細胞増殖因子
US6130050A (en) Method for detection of growth differentiation factor-12 polypeptide
AU2003200912B2 (en) Novel protein and processes for producing the same
JP2001190293A (ja) 組換肝実質細胞増殖因子
JPH1070990A (ja) 組換肝実質細胞増殖因子
JP2003024066A (ja) ヒトｃｃｎ−様増殖因子

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 116223

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: ATLAS PHARMACEUTICALS INC.

Free format text: ATLAS PHARMACEUTICALS INC.